Human Interleukin-10 Expression in T/Natural Killer-Cell Lymphomas: Association with Anaplastic Large Cell Lymphomas and Nasal Natural Killer-Cell Lymphomas

This publication has 48 references indexed in Scilit:

• Th2 Cytokine mRNA Expression in Primary Cutaneous CD30-Positive Lymphoproliferative Disorders: Successful Treatment With Recombinant Interferon-γ
  Journal of Investigative Dermatology, 1996
• Interleukin 10 pretreatment protects target cells from tumor- and allo-specific cytotoxic T cells and downregulates HLA class I expression.
  The Journal of Experimental Medicine, 1994
• Differential Effects of IL‐10 on Proliferation and Cytokine Production of Human γ/δ and α/β T cells
  Scandinavian Journal of Immunology, 1994
• In vivo production of interleukin‐10 by malignant cells in AIDS lymphomas
  European Journal of Immunology, 1992
• Biological properties of interleukin 10
  Journal of Clinical Immunology, 1992
• Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.
  The Journal of Experimental Medicine, 1991
• Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.
  The Journal of Experimental Medicine, 1991
• Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas
  Cellular Immunology, 1990
• Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.
  The Journal of Experimental Medicine, 1989
• UPDATED KIEL CLASSIFICATION FOR LYMPHOMAS
  The Lancet, 1988